Synthesis and characterisation of novel beta-cyclodextrin based Fe3O4 nanocomposite: adsorption behaviour and photocatalytic dye degradation studies
Sign Up to like & getrecommendations! Published in 2024 at "International Journal of Environmental Analytical Chemistry"
DOI: 10.1080/03067319.2024.2373358
Abstract: ABSTRACT Novel Beta-Cyclodextrin-based Fe3O4 nanocomposite has been synthesised through copolymerisation by incorporating Fe3O4 nanoparticles into the polymer matrix. Ultraviolet-Visible (UV-Visible) spectroscopy, Fourier transform infrared (FTIR) spectroscopy, Thermogravimetric (TGA) analysis, Point of Zero Charge, X-ray diffraction… read more here.
Keywords: spectroscopy; degradation; adsorption; fe3o4 nanocomposite ... See more keywords
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Anti-infective Therapy"
DOI: 10.1080/14787210.2023.2169131
Abstract: ABSTRACT Introduction The choice of best therapeutic strategy for difficult-to-treat resistance (DTR) Gram-negative infections currently represents an unmet clinical need. Areas covered This review provides a critical reappraisal of real-world evidence supporting the role of… read more here.
Keywords: dtr gram; difficult treat; novel beta; negative infections ... See more keywords
Promising Future of Novel Beta-Lactam Antibiotics Against Bacterial Resistance
Sign Up to like & getrecommendations! Published in 2025 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s551862
Abstract: Background Antimicrobial resistance is a growing global concern that compromises the efficacy of antibiotics, particularly due to the misuse and overuse of these agents. Beta-lactam antibiotics, widely used for their broad-spectrum activity, are increasingly threatened… read more here.
Keywords: resistance; beta; beta lactam; novel beta ... See more keywords
In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2024.1282480
Abstract: Objective: FL058 is a novel beta-lactamase inhibitor with a broad spectrum of activity and a favorable safety profile. The objective of this study was to evaluate pharmacokinetic/pharmacodynamic (PK/PD) relationships for the combination of FL058 and… read more here.
Keywords: fl058 novel; combined meropenem; beta lactamase; lactamase inhibitor ... See more keywords